A phase III randomized trial of gantenerumab in prodromal Alzheimer’s diseasePaulo Fontoura, Susanne Ostrowitzki, Robert Lasser et al.|Alzheimer s Research & Therapy|2017Cited by 568
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderGregory W. Mattingly, D. Wayne Goodman, Ben Adeyi et al.|BMC Psychiatry|2013Cited by 31